WILMINGTON, Del., May 23, 2017 /PRNewswire/ -- The Chemours
Company (Chemours) (NYSE: CC), a global chemistry company with
leading market positions in titanium technologies, fluoroproducts
and chemical solutions, today announced it had completed its
offering (the "offering") of $500,000,000 aggregate principal amount of its
5.375% Senior Notes due 2027.
Mark Newman, Senior Vice
President and CFO of Chemours stated, "As previously announced, we
intend to use the net proceeds of the offering for general
corporate purposes, including our portion of the global settlement
of the multi-district PFOA litigation between DuPont and the
plaintiffs, if finalized. This offering allows Chemours to enhance
its financial flexibility as we continue to strengthen our
company."
Credit Suisse Securities (USA)
LLC, Barclays Capital Inc., Citigroup Global Markets Inc., J.P.
Morgan Securities LLC and TD Securities (USA) LLC are acting as joint-book running
managers for the offering. HSBC Securities (USA) Inc., Mizuho Securities USA Inc. and RBC Capital Markets LLC are
acting as co-managers for the offering. The offering is being made
by means of a prospectus supplement. You may review these documents
for free by visiting EDGAR on the SEC's website, at www.sec.gov.
Alternatively, these documents may be obtained from Credit Suisse
Securities (USA) LLC by calling
toll-free at 1-800-221-1037, J.P. Morgan Securities LLC collect at
1-212-834-4533, Citigroup Global Markets Inc. toll-free at
1-800-831-9146, Barclays Capital Inc. toll-free at 1-888-603-5847
and TD Securities (USA) LLC
toll-free at 1-855-495-9846.
This press release is neither an offer to sell nor a
solicitation of an offer to buy any securities, nor shall there be
any offer, solicitation or sale in any jurisdiction in which such
offer, solicitation or sale would be unlawful. Such an offer can
only be made by delivery of a prospectus and prospectus supplement,
if applicable, that have been filed with the Securities and
Exchange Commission.
About The Chemours Company
The Chemours Company (NYSE:
CC) helps create a colorful, capable and cleaner world through the
power of chemistry. Chemours is a global leader in titanium
technologies, fluoroproducts and chemical solutions, providing its
customers with solutions in a wide range of industries with
market-defining products, application expertise and chemistry-based
innovations. Chemours ingredients are found in plastics and
coatings, refrigeration and air conditioning, mining and general
industrial manufacturing. Our flagship products include
prominent brands such as Teflon™,
Ti-Pure™, Krytox™, Viton™,
Opteon™, Freon™ and
Nafion™. Chemours has approximately 7,000
employees and 26 manufacturing sites serving approximately 4,000
customers in North America,
Latin America, Asia-Pacific and Europe. Chemours is
headquartered in Wilmington,
Delaware and is listed on the NYSE under the symbol
CC. For more information please visit chemours.com
Forward-Looking Statements
This press release contains
forward-looking statements, within the meaning of the federal
securities laws, that involve risks and uncertainties.
Forward-looking statements provide current expectations of future
events based on certain assumptions and include any statement that
does not directly relate to any historical or current fact. The
words "believe," "expect," "anticipate," "plan," "estimate,"
"target," "project" and similar expressions, among others,
generally identify "forward-looking statements," which speak only
as of the date the statements were made. These forward-looking
statements address, among other things, the offering, our agreement
with DuPont relating to the MDL Settlement, resolution of
environmental liabilities, litigation and other contingencies,
anticipated future operating and financial performance, business
plans and prospects, that are subject to substantial risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statements. Forward-looking
statements are based on certain assumptions and expectations of
future events which may not be accurate or realized.
Forward-looking statements also involve risks and uncertainties,
many of which are beyond Chemours' control. Additionally, there may
be other risks and uncertainties that Chemours is unable to
identify at this time or that Chemours does not currently expect to
have a material impact on its business. Factors that could cause or
contribute to these differences include whether the offering is
completed and other risks, uncertainties and other factors
discussed in our filings with the Securities and Exchange
Commission, including our Annual Report on Form 10-K for the year
ended December 31, 2016. Chemours
assumes no obligation to revise or update any forward-looking
statement for any reason, except as required by law.
CONTACT
MEDIA
Alvenia
Scarborough
Director of Corporate Communications
and Brand
Marketing
+1.302.773.4507
media@chemours.com
INVESTORS
Alisha
Bellezza
Treasurer and Director of Investor
Relations
+1.302.773.2263
investor@chemours.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-chemours-company-announces-completion-of-500000000-of-5375-senior-notes-due-2027-300462451.html
SOURCE The Chemours Company